MFDS — authorised 6 March 2018
- Marketing authorisation holder: TAIMED BIOLOGICS USA
- Status: likely_approved
MFDS authorised Trogarzo on 6 March 2018
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MFDS authorised it on 6 March 2018.
TAIMED BIOLOGICS USA holds the South Korean marketing authorisation.